Related Experiment Video
Updated: Aug 7, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Targeting interleukin-2 as a treatment for psoriasis
1Department of Dermatology, North Staffordshire Hospital, Stoke-on Trent, UK. salim@doctors.org.uk
Current Opinion in Investigational Drugs (London, England : 2000)
|January 5, 2002
Summary
Interleukin-2 (IL-2) drives psoriasis by activating T-cells. New therapies targeting IL-2 production or action offer promising treatments for this inflammatory skin condition.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Interleukin-2 (IL-2) is a critical cytokine in immune responses.
- IL-2 signaling promotes T-cell activation, contributing to inflammatory conditions.
- Psoriasis pathogenesis involves dysregulated T-cell activity driven by IL-2.
Purpose of the Study:
- To review recent therapeutic strategies targeting the IL-2 pathway in psoriasis.
- To discuss novel approaches for inhibiting IL-2 production or action.
- To highlight the clinical relevance of IL-2 blockade in managing psoriasis.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of therapeutic mechanisms targeting IL-2.
- Discussion of emerging IL-2-targeted therapies.
Main Results:
- Several novel therapies effectively block IL-2 signaling.
- These therapies demonstrate potential in reducing T-cell activation in psoriasis models.
- Targeting IL-2 offers a specific approach to psoriasis treatment.
Conclusions:
- IL-2 blockade represents a promising therapeutic avenue for psoriasis.
- Targeting the IL-2 pathway provides a mechanism-specific treatment strategy.
- Further research and clinical trials are warranted for IL-2-targeted therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...